TRIALSITEIQ PUBLIC FEASIBILITY SCORECARD · GRADE C

NCT06606561: NANOVAE to Treat Knee Osteoarthritis (KOA)

Sponsor: Nova Vita Laboratory · Phase: PHASE1/PHASE2 · Area: IMMUNOLOGY · Target Enrollment: 24 pts

Competing Trials Overlap

3 Active Trials

Excess Burn Exposure

$9,384,000

Rescue Site Savings

+$6,187,575

Unlock Full NCT06606561 Backup Super-Site Packet ($49 One-Time Pass)

Download the complete list of top-decile low-cannibalization clinical sites, verified Principal Investigator (PI) direct emails/phones, and protocol optimization benchmarks.

Download $49 NCT06606561 Rescue Dossier →